TSF & CPI Missed Expectations,Property Demand Weakened
China Policy:Credit growth is expected to rebound in 2023
China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters
1H24 preview: margin weakness priced in; expect gradual ASP/margin recovery in 2H
–Release of pent-up demand as expected
China Pharmaceutical & Healthcare - Expecting global funding recovery in the coming quarters
China Property SectorNBS Nov data in line, expect new policy in BJ/SH to boost secondary market in Dec
2024 earnings way below expectations; outlook remains challenging
1Q23E profit beat expectations; Multiple catalysts ahead
U.S. Inflation Expectations During the Pandemic